{"id":1200,"date":"2018-11-06T17:56:00","date_gmt":"2018-11-06T17:56:00","guid":{"rendered":"https:\/\/pepharm.gr\/%cf%83%ce%b5%ce%bc%ce%b9%ce%bd%ce%ac%cf%81%ce%b9%ce%bf-quality-by-design-qbd\/"},"modified":"2018-11-06T17:56:00","modified_gmt":"2018-11-06T17:56:00","slug":"%cf%83%ce%b5%ce%bc%ce%b9%ce%bd%ce%ac%cf%81%ce%b9%ce%bf-quality-by-design-qbd","status":"publish","type":"post","link":"https:\/\/pepharm.gr\/en\/%cf%83%ce%b5%ce%bc%ce%b9%ce%bd%ce%ac%cf%81%ce%b9%ce%bf-quality-by-design-qbd\/","title":{"rendered":"\u03a3\u03b5\u03bc\u03b9\u03bd\u03ac\u03c1\u03b9\u03bf: Quality by Design (QbD)"},"content":{"rendered":"
\n
\n
<\/div>\n

\u0397 \u03a0\u03b1\u03bd\u03b5\u03bb\u03bb\u03ae\u03bd\u03b9\u03b1 \u0388\u03bd\u03c9\u03c3\u03b7 \u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03bf\u03c0\u03bf\u03b9\u03ce\u03bd, \u03c3\u03c4\u03bf \u03c0\u03bb\u03b1\u03af\u03c3\u03b9\u03bf \u03c4\u03b7\u03c2 \u03c3\u03c5\u03bd\u03b5\u03c7\u03b9\u03b6\u03cc\u03bc\u03b5\u03bd\u03b7\u03c2 \u03b5\u03c0\u03b1\u03b3\u03b3\u03b5\u03bb\u03bc\u03b1\u03c4\u03b9\u03ba\u03ae\u03c2 \u03b1\u03bd\u03ac\u03c0\u03c4\u03c5\u03be\u03b7\u03c2 (CPD) \u03c4\u03c9\u03bd \u03bc\u03b5\u03bb\u03ce\u03bd \u03c4\u03b7\u03c2, \u03b4\u03b9\u03bf\u03c1\u03b3\u03b1\u03bd\u03ce\u03bd\u03b5\u03b9 \u03c4\u03b7\u03bd \u03a0\u03b1\u03c1\u03b1\u03c3\u03ba\u03b5\u03c5\u03ae 30 \u039d\u03bf\u03b5\u03bc\u03b2\u03c1\u03af\u03bf\u03c5 2018<\/span><\/b>, \u03c3\u03b5\u03bc\u03b9\u03bd\u03ac\u03c1\u03b9\u03bf \u03bc\u03b5 \u03b8\u03ad\u03bc\u03b1:<\/p>\n

“Quality by Design in Pharmaceutical Product and Process Development”.<\/b><\/div>\n
\u03a4\u03bf \u03c3\u03b5\u03bc\u03b9\u03bd\u03ac\u03c1\u03b9\u03bf \u03b8\u03b1 \u03ad\u03c7\u03b5\u03b9 \u03b4\u03b9\u03ac\u03c1\u03ba\u03b5\u03b9\u03b1 6 \u03b5\u03ba\u03c0\u03b1\u03b9\u03b4\u03b5\u03c5\u03c4\u03b9\u03ba\u03ce\u03bd \u03c9\u03c1\u03ce\u03bd \u03ba\u03b1\u03b9 \u03b8\u03b1 \u03b4\u03b9\u03b5\u03be\u03b1\u03c7\u03b8\u03b5\u03af \u03c3\u03c4\u03bf \u03a0\u03bf\u03bb\u03b5\u03bc\u03b9\u03ba\u03cc \u039c\u03bf\u03c5\u03c3\u03b5\u03af\u03bf \u0391\u03b8\u03b7\u03bd\u03ce\u03bd. \u0393\u03b9\u03b1 \u03bd\u03b1 \u03b4\u03b7\u03bb\u03ce\u03c3\u03b5\u03c4\u03b5 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03bf\u03c7\u03ae \u03c3\u03c5\u03bc\u03c0\u03bb\u03b7\u03c1\u03ce\u03c3\u03c4\u03b5 \u03c4\u03b7\u03bd Online \u03c6\u03cc\u03c1\u03bc\u03b1 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03bf\u03c7\u03ae\u03c2 \u0395\u0394\u03a9<\/a>.<\/p>\n

\u03a0\u03b1\u03c1\u03b1\u03c4\u03af\u03b8\u03b5\u03c4\u03b1\u03b9 \u03c4\u03bf \u03b1\u03bd\u03b1\u03bb\u03c5\u03c4\u03b9\u03ba\u03cc \u03c0\u03c1\u03cc\u03b3\u03c1\u03b1\u03bc\u03bc\u03b1 \u03c4\u03bf\u03c5 \u03c3\u03b5\u03bc\u03b9\u03bd\u03b1\u03c1\u03af\u03bf\u03c5:<\/p>\n

<\/a><\/p>\n

<\/p>\n\n\n\n\n\n\n\n\n\n\n\n
\n
10<\/span>:<\/span>3<\/span>0<\/span><\/span><\/div>\n<\/td>\n
\n
–<\/span><\/span><\/div>\n<\/td>\n
\n
11<\/span>:<\/span>0<\/span>0<\/span><\/span><\/div>\n<\/td>\n
\n
Registration<\/span><\/b><\/div>\n<\/td>\n<\/tr>\n
\n
11<\/span>:<\/span>0<\/span>0<\/span><\/span><\/div>\n<\/td>\n
\n
–<\/span><\/div>\n<\/td>\n
\n
11:30<\/span><\/div>\n<\/td>\n
\n
The Quality Guidelines: Linking pharmaceutical development and manufacturing with patient safety<\/span><\/b><\/div>\n
D.M. Rekkas, , Associate Professor, Dpt. of Pharmacy, NKUA<\/span><\/i><\/div>\n<\/td>\n<\/tr>\n
\n
1<\/span>1<\/span>:<\/span>30<\/span><\/span><\/div>\n<\/td>\n
\n
–<\/span><\/span><\/div>\n<\/td>\n
\n
1<\/span>2<\/span>:<\/span>30<\/span><\/span><\/div>\n<\/td>\n
\n
Quality by Design (QbD) knowledge management and statistical thinking<\/span><\/b><\/div>\n
D.M. Rekkas, , Associate Professor, Dpt.of Pharmacy, NKUA<\/span><\/i><\/span><\/b><\/div>\n<\/td>\n<\/tr>\n
\n
1<\/span>2<\/span>:<\/span>30<\/span><\/span><\/div>\n<\/td>\n
\n
–<\/span><\/span><\/div>\n<\/td>\n
\n
12:<\/span>4<\/span>5<\/span><\/span><\/div>\n<\/td>\n
\n
Coffee Break<\/span><\/b><\/span><\/b><\/div>\n<\/td>\n<\/tr>\n
\n
12:<\/span>4<\/span>5<\/span><\/span><\/div>\n<\/td>\n
\n
–<\/span><\/span><\/div>\n<\/td>\n
\n
13:<\/span>4<\/span>5<\/span><\/span><\/div>\n<\/td>\n
\n
Introduction to design of experiments<\/span><\/b><\/span><\/b><\/div>\n
D.M. Rekkas, , Associate Professor<\/span><\/i>,<\/span><\/i> <\/span><\/i>Dpt. of Pharmacy<\/span><\/i>, NKUA<\/span><\/i><\/span><\/b><\/div>\n<\/td>\n<\/tr>\n
\n
1<\/span>3<\/span>:<\/span>4<\/span>5<\/span><\/span><\/div>\n<\/td>\n
\n
–<\/span><\/span><\/div>\n<\/td>\n
\n
14:<\/span>1<\/span>5<\/span><\/span><\/div>\n<\/td>\n
\n
Break <\/span><\/b><\/span><\/b><\/div>\n<\/td>\n<\/tr>\n
\n
14:<\/span>1<\/span>5<\/span><\/span><\/div>\n<\/td>\n
\n
–<\/span><\/span><\/div>\n<\/td>\n
\n
16:<\/span>1<\/span>5<\/span><\/span><\/div>\n<\/td>\n
\n
QRM in product and process development<\/span><\/b><\/span><\/b><\/div>\n
S.N. Politis, MSc, PhD, Director Formulation Development Genepharm SA<\/span><\/i><\/span><\/i><\/div>\n<\/td>\n<\/tr>\n
\n
16:15<\/span><\/span><\/div>\n<\/td>\n
\n
<\/div>\n<\/td>\n
\n
16:45<\/span><\/span><\/div>\n<\/td>\n
\n
Case study<\/span><\/b><\/span><\/b><\/div>\n
A DoE application example for addressing process variability.<\/span><\/i><\/span><\/i><\/div>\n
V.Nyktaraki and P.Koutsoukos, Pharmacy  <\/span>students, Dpt.of Pharmacy,NKUA<\/span><\/i><\/div>\n<\/td>\n<\/tr>\n
\n
16:45<\/span><\/span><\/div>\n<\/td>\n
\n
–<\/span><\/span><\/div>\n<\/td>\n
\n
17:<\/span>0<\/span>0<\/span><\/span><\/div>\n<\/td>\n
\n
Q&As<\/span><\/b><\/span><\/b><\/div>\n
<\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u0395\u03b9\u03c3\u03b7\u03b3\u03b7\u03c4\u03ad\u03c2 \u03c4\u03bf\u03c5 \u03c3\u03b5\u03bc\u03b9\u03bd\u03b1\u03c1\u03af\u03bf\u03c5 QbD \u03b8\u03b1 \u03b5\u03af\u03bd\u03b1\u03b9 \u03bf\u03b9:<\/p>\n

\u03a1\u03ad\u03ba\u03ba\u03b1\u03c2 \u0394\u03b7\u03bc\u03ae\u03c4\u03c1\u03b9\u03bf\u03c2<\/b>
\u0391\u03bd\u03b1\u03c0\u03bb\u03b7\u03c1\u03c9\u03c4\u03ae\u03c2 \u03ba\u03b1\u03b8\u03b7\u03b3\u03b7\u03c4\u03ae\u03c2 \u03c3\u03c4\u03bf \u03a4\u03bc\u03ae\u03bc\u03b1 \u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae\u03c2 \u0395\u039a\u03a0\u0391<\/p>\n

\u03a0\u03bf\u03bb\u03af\u03c4\u03b7\u03c2 \u03a3\u03c4\u03b1\u03cd\u03c1\u03bf\u03c2<\/b>
\u0394\u03b9\u03b5\u03c5\u03b8\u03c5\u03bd\u03c4\u03ae\u03c2 Formulation Development Genepharm SA, \u0394\u03b9\u03b4\u03ac\u03ba\u03c4\u03c9\u03c1 \u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae\u03c2 \u03c3\u03c4\u03bf \u03a4\u03bc\u03ae\u03bc\u03b1 \u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae\u03c2 \u0395\u039a\u03a0\u0391<\/p>\n

\u039d\u03c5\u03ba\u03c4\u03b1\u03c1\u03ac\u03ba\u03b7 \u0392\u03b1\u03c3\u03b9\u03bb\u03b9\u03ba\u03ae<\/b>
\u03a6\u03bf\u03b9\u03c4\u03ae\u03c4\u03c1\u03b9\u03b1 \u03c3\u03c4\u03bf \u03a4\u03bc\u03ae\u03bc\u03b1 \u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae\u03c2 \u0395\u039a\u03a0\u0391<\/p>\n

\u039a\u03bf\u03c5\u03c4\u03c3\u03bf\u03cd\u03ba\u03bf\u03c2 \u03a0\u03b1\u03bd\u03b1\u03b3\u03b9\u03ce\u03c4\u03b7\u03c2<\/b>
\u03a6\u03bf\u03b9\u03c4\u03b7\u03c4\u03ae\u03c2 \u03c3\u03c4\u03bf \u03a4\u03bc\u03ae\u03bc\u03b1 \u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae\u03c2 \u0395\u039a\u03a0\u0391<\/p>\n

\u03a4\u03bf \u03ba\u03cc\u03c3\u03c4\u03bf\u03c2 \u03c0\u03b1\u03c1\u03b1\u03ba\u03bf\u03bb\u03bf\u03cd\u03b8\u03b7\u03c3\u03b7\u03c2 \u03b1\u03c5\u03c4\u03bf\u03cd \u03c4\u03bf\u03c5 \u03b5\u03ba\u03c0\u03b1\u03b9\u03b4\u03b5\u03c5\u03c4\u03b9\u03ba\u03bf\u03cd \u03c3\u03b5\u03bc\u03b9\u03bd\u03b1\u03c1\u03af\u03bf\u03c5 \u03b1\u03bd\u03ad\u03c1\u03c7\u03b5\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b1 186 \u20ac<\/b> (\u03c3\u03c5\u03bc\u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03c4\u03b1\u03b9 \u03bf \u03a6\u03a0\u0391 24%). \u0397 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ae \u03c4\u03bf\u03c5 \u03c0\u03bf\u03c3\u03bf\u03cd \u03bc\u03c0\u03bf\u03c1\u03b5\u03af \u03bd\u03b1 \u03b3\u03af\u03bd\u03b5\u03b9 \u03bc\u03cc\u03bd\u03bf \u03bc\u03b5 \u03c4\u03c1\u03b1\u03c0\u03b5\u03b6\u03b9\u03ba\u03ae \u03ba\u03b1\u03c4\u03ac\u03b8\u03b5\u03c3\u03b7<\/span> \u03c3\u03c4\u03bf\u03bd \u03b1\u03ba\u03cc\u03bb\u03bf\u03c5\u03b8\u03bf \u03bb\u03bf\u03b3\u03b1\u03c1\u03b9\u03b1\u03c3\u03bc\u03cc:<\/p>\n

<\/p>\n

<\/div>\n
\u03a4\u03c1\u03ac\u03c0\u03b5\u03b6\u03b1 \u03a0\u03b5\u03b9\u03c1\u03b1\u03b9\u03ce\u03c2<\/b><\/div>\n
\u0391\u03c1. \u039b\u03bf\u03b3\u03b1\u03c1\u03b9\u03b1\u03c3\u03bc\u03bf\u03cd 6435-010070-731<\/div>\n
IBAN: GR 9101714350006435010070731<\/div>\n
\u0394\u03b9\u03ba\u03b1\u03b9\u03bf\u03cd\u03c7\u03bf\u03c2: \u03a0\u0391\u039d\u0395\u039b\u039b\u0397\u039d\u0399\u0391 \u0395\u039d\u03a9\u03a3\u0397 \u03a6\u0391\u03a1\u039c\u0391\u039a\u039f\u03a0\u039f\u0399\u03a9\u039d (\u03a0\u0395\u03a6)<\/div>\n
<\/div>\n
\n

\u03a0\u03b1\u03c1\u03b1\u03ba\u03b1\u03bb\u03bf\u03cd\u03bc\u03b5 \u03cc\u03c0\u03c9\u03c2 \u03c3\u03b7\u03bc\u03b5\u03b9\u03ce\u03c3\u03b5\u03c4\u03b5 \u03c3\u03c4\u03b7\u03bd \u03b1\u03b9\u03c4\u03b9\u03bf\u03bb\u03bf\u03b3\u03af\u03b1 \u03c4\u03b7\u03c2 \u03ba\u03b1\u03c4\u03ac\u03b8\u03b5\u03c3\u03b7\u03c2 \u03c3\u03b1\u03c2 \u03c4\u03bf \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c4\u03b7\u03c2 \u03b5\u03c4\u03b1\u03b9\u03c1\u03af\u03b1\u03c2 \u03c3\u03b1\u03c2 \u03b1\u03bd \u03c0\u03c1\u03cc\u03ba\u03b5\u03b9\u03c4\u03b1\u03b9 \u03b3\u03b9\u03b1 \u03b5\u03c4\u03b1\u03b9\u03c1\u03b9\u03ba\u03ae \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03bf\u03c7\u03ae, \u03b5\u03af\u03c4\u03b5 \u03c4\u03bf \u03bf\u03bd\u03bf\u03bc\u03b1\u03c4\u03b5\u03c0\u03ce\u03bd\u03c5\u03bc\u03bf \u03c3\u03b1\u03c2 \u03b1\u03bd \u03c0\u03c1\u03cc\u03ba\u03b5\u03b9\u03c4\u03b1\u03b9 \u03b3\u03b9\u03b1 \u03b1\u03c4\u03bf\u03bc\u03b9\u03ba\u03ae \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03bf\u03c7\u03ae. \u03a4\u03ad\u03bb\u03bf\u03c2 \u03b5\u03c6\u03b9\u03c3\u03c4\u03bf\u03cd\u03bc\u03b5 \u03c4\u03b7\u03bd \u03c0\u03c1\u03bf\u03c3\u03bf\u03c7\u03ae \u03c3\u03b1\u03c2 \u03c3\u03c4\u03b1 \u03c0\u03b1\u03c1\u03b1\u03ba\u03ac\u03c4\u03c9:<\/p><\/div>\n